New Delhi: The Delhi High Court while hearing a Public Interest Litigation (PIL) petition has ordered All India Institute of Medical Sciences, (AIIMS), New Delhi, to import Dexell injection. A woman whose four-year-old son has been suffering from a kidney-related ailment and the child has been undergoing treatment at AIIMS in New Delhi.
The High Court converted the woman's petitioner's plea into PIL. The complaint was routed through High Court's Registrar General office via e mail. In the petition, the woman stated that the Dexell injection was not available in the country. But, this injection was urgently required for her son's treatment. The petitioner further stated she was asked by AIIMS officials that she should seek remedial measures from ESIC dispensary situated at Nand Nagari, New Delhi. The ailing child's father has been empanelled for availing of medical coverage under the Employees' State Insurance Corporation scheme at the ESIC dispensary.
The petitioner was turned away by the authorities of ESIC dispensary, stating that the said injection was not available in the country and could not be purchased. A division bench of the High Court comprising Chief Justice Satish Chandra Sharma and Justice Sachin Dutta gave orders to AIIMS to import the Dexell injection so that the ailing child's treatment will be facilitated.